|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/20 | |
| C07D 213/42 | |||
| A61K 31/395 | |||
| A61K 45/06 |
| (11) | Patento numeris | 2178512 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08771565.2 |
| Europos patento paraiškos padavimo data | 2008-06-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-04-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2011-03-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/067629 |
| Data | 2008-06-20 |
| (87) | Numeris | WO 2009/002826 |
| Data | 2008-12-31 |
| (30) | Numeris | Data | Šalis |
| 945691 P | 2007-06-22 | US |
| (72) |
KOO, Otilia May Yue, US
NIKFAR, Faranak, US
DIAZ, Steven, US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 05843-4000,
US
|
| (54) | TABLETED COMPOSITIONS CONTAINING ATAZANAVIR |
| TABLETED COMPOSITIONS CONTAINING ATAZANAVIR |